Organometallics
Article
which gave the total volume as 1400 μL. From this boric ester stock
solution, 400 μL was transferred to a J. Young NMR tube and capped
with a rubber septum. This was repeated a total of three times to
create three identical samples. To prepare the 7.5 mol % IPrAuTFA
stock solution, the IPrAuTFA catalyst (9.2 mg, 0.013 mmol) was
(152 mg, 0.43 mmol). In this vial was placed MeCN (2 mL), and the
reaction mixture was stirred for 5 min. Workup identical with that for
the synthesis of IPrAu(NCMe)BF was used to obtain the product as a
4
1
white solid (344 mg, 99%). H NMR (600 MHz, CDCl ): δ 7.59 (t, J
3
= 7.9 Hz, 2H), 7.36 (d, J = 7.8 Hz, 4H), 7.33 (s, 2H), 2.45 (septet, J =
6.9 Hz), 2.33 (s, 3H), 1.32 (d, J = 6.9 Hz, 12H), 1.25 (d, J = 6.8 Hz,
12H). This spectrum is in agreement with previously reported spectral
dissolved in d -toluene (350 μL).
8
Example Given for NaCl-Free Synthesis of 1 (eq 5, Top Arrow)
and Subsequent Oxyboration Reaction using 5 mol % of IPrAuTFA.
3
6
data.
1
3 (34.0 mg, 0.175 mmol) was dissolved in d -toluene (250 μL) and
Examination of Gold Catalysts with Varying Counterions
Using NaCl-Free Synthesis of 1. Preparation of 1. To a cooled
8
placed in a vial containing B-chlorocatecholborane (27.0 mg, 0.175
mmol). Additional d -toluene (250 μL) was used to rinse and transfer.
The solution was allowed to sit for 20 min, and the HCl byproduct
and solvent were removed under vacuum for 40 min. The resulting
solution of 13 (0.265 g, 1.36 mmol) in Et
mL Schlenk tube was slowly added a solution of B-chlorocatecholbor-
ane (0.210 g, 1.36 mmol) in Et O (5 mL). The reaction mixture was
2
O (5 mL) at −78 °C in a 25
8
2
compound 2 was dissolved in d -toluene (1400 μL). From this boric
stirred while it was warmed to room temperature for 1 h. The HCl
byproduct and the solvent were removed in vacuo to quantitatively
8
ester stock solution, 400 μL was transferred to a J. Young NMR tube
and the tube was capped with a rubber septum. This was repeated a
total of three times to create three identical samples. To prepare the 5
mol % IPrAuTFA stock solution, the IPrAuTFA catalyst (6.1 mg,
yield 1 as a yellow oil, which was directly used to prepare a 0.272 M
1
stock solution of 1 in d
NMR (600 MHz, d
-toluene using a 5 mL volumetric flask. H
8
-toluene): δ 7.38 (dd, J = 7.7, 1.7 Hz, 1H), 7.24−
8
0
.0088 mmol) was dissolved in d -toluene (350 μL).
General Procedure for Kinetic Experiments. A J. Young NMR
7.20 (m, 2H), 6.99−6.97 (m, 1 H), 6.92 (td, J = 7.6, 1.7 Hz, 1H),
8
6.86−6.84 (m, 3H), 6.83−6.80 (m, 2H), 6.75 (td, J = 7.6, 1.2 Hz, 1H),
11
tube containing 2 (from the above procedure) and one gastight
syringe with 100 μL of the IPrAuTFA solution, capped with a rubber
stopper, were removed from the glovebox. The rubber septum on the
J. Young NMR tube was wrapped in Parafilm. The sample in the J.
Young NMR tube was immediately transported to the NMR
spectrometer, which underwent temperature calibration before sample
injection. The IPrAuTFA solution was injected using the gastight
syringe into the J. Young NMR tube. This tube was shaken and
inserted into the NMR spectrometer. Acquisition of spectra
immediately followed. The acquisition time was set to 6 s. A 90°
pulse was used. The line broadening was set to 1 Hz. There was one
scan taken per experiment, and there were no dummy scans . A total of
6.69−6.65 (m, 2H). B NMR (193 MHz, d -toluene): δ 23.1. These
8
4
spectra are in agreement with previously reported spectral data.
General Procedure for Catalyst Screen. A dram vial was charged
with the gold complex (0.0068 mmol, 5 mol %). In this vial were
placed 1 (500 μL, 0.136 mmol, 0.272 M) and 1,3,5-triisopropylben-
zene (11.0 μL, 0.0453 mmol) as an internal standard using a gastight
syringe. The suspension was mixed and transferred to a J. Young NMR
tube using a Pasteur pipet. The reaction was either kept at ambient
temperature or heated at a specified temperature. The reaction was
1
monitored by H NMR spectroscopy over time by observing growing
signals of the product: doublet centered at δ 8.35 ppm and multiplet
centered at δ 8.14 ppm.
5
0 experiments were conducted sequentially with 34 s delays between
experiments.
Synthesis of Bu NTFA. The synthetic procedure was adapted
ASSOCIATED CONTENT
Supporting Information
■
4
S
*
38
from the literature. Trifluoroacetic acid (0.04 mL, 0.5 mmol) was
added dropwise into a 10 mL round-bottom flask containing trimethyl
phosphate (0.7 mL, 6.0 mmol). To this stirred solution was added
Bu NBr (161 mg, 0.500 mmol). The reaction mixture was stirred at 60
4
°
C overnight. Excess trimethyl phosphate was removed via vacuum
Additional kinetic plots and NMR spectra (PDF)
distillation at 85 °C. The resultant residue was dissolved in CH Cl (2
mL), followed by addition of 25 drops of a 10% (w/v) NH OH
aqueous solution. Once the pH of the solution was neutralized (pH 7),
water (2 mL) was added. The organic layer was separated, and the
aqueous layer was extracted with CH Cl (2 × 2 mL). The combined
2
2
4
AUTHOR INFORMATION
■
2
2
organic layers were concentrated and dried under high vacuum at 100
C overnight. The product was isolated as a beige solid (133 mg, 75%)
Notes
°
1
The authors declare the following competing financial
interest(s): US Pat. No. 9,238,661.
and used without further purification. H NMR (600 MHz, CDCl ): δ
3
3
.32−3.27 (m, 8H), 1.68−1.61 (m, 8H), 1.44 (sextet, J = 7.4 Hz, 8H),
1
.01 (t, J = 7.4 Hz, 12H). 19F NMR (376 MHz, CDCl ): δ −75.1.
3
ACKNOWLEDGMENTS
This work was supported by a grant from the NIH
1R01GM098512-01) and by the University of California,
These spectra are in agreement with previously reported spectral
■
(
38
data.
Synthesis of IPrAu(NCMe)BF . The synthetic procedure was
adapted from the literature. A dram vial equipped with a magnetic
stir bar was charged with IPrAuCl (300 mg, 0.480 mmol) and AgBF4
4
36
Irvine.
(
94 mg, 0.48 mmol). In this vial was placed MeCN (2 mL), and the
REFERENCES
reaction mixture was stirred for 5 min. For workup, the reaction
solvent was separated from the AgCl byproduct and concentrated in
vacuo. The resulting crude residue was diluted in CH Cl (2 mL) and
filtered through a short plug of silica gel to remove residual silver salts.
Additional CH Cl (2 × 2 mL) was used to ensure complete elution of
the product from the silica gel. After concentration of the filtrate in
■
(1) Miyaura, N. Hydroboration, Diboration, Silylboration, and
Stannylboration. In Catalytic Heterofunctionalization; Togni, A.,
Grutzmacher, H., Eds.; Wiley-VCH: Weinheim, Germany, 2001; pp
2
2
̈
1−45.
2
2
(2) Suginome, M. Chem. Rec. 2010, 10, 348−358.
(3) Barbeyron, R.; Benedetti, E.; Cossy, J.; Vasseur, J.-J.; Arseniyadis,
S.; Smietana, M. Tetrahedron 2014, 70, 8431−8452.
(4) Hirner, J. J.; Faizi, D. J.; Blum, S. A. J. Am. Chem. Soc. 2014, 136,
4740−4745.
1
vacuo, the product was obtained as a white solid (340 mg, 99%). H
NMR (600 MHz, CDCl ): δ 7.58 (t, J = 7.9 Hz, 2H), 7.37 (s, 2H),
3
7
.35 (d, J = 7.8 Hz, 4H), 2.44 (septet, J = 6.9 Hz), 2.41 (s, 3H), 1.30
(
d, J = 6.9 Hz, 12H), 1.25 (d, J = 6.8 Hz, 12H). This spectrum is in
36
agreement with previously reported spectral data.
(5) Chong, E.; Blum, S. A. J. Am. Chem. Soc. 2015, 137, 10144−
10147.
(6) Tu, K. N.; Hirner, J. J.; Blum, S. S. Org. Lett. 2016, 18, 480.
Synthesis of IPrAu(NCMe)SbF . The synthetic procedure was
6
36
adapted from the literature. A dram vial equipped with a magnetic
stir bar was charged with IPrAuCl (250 mg, 0.40 mmol) and AgSbF6
(7) Dorel, R.; Echavarren, A. M. Chem. Rev. 2015, 115, 9028−9072.
G
Organometallics XXXX, XXX, XXX−XXX